|
1
|
Little EG and Eide M: Update on the
recurrence state of melanoma incidence. Dematol Clin. 30:355–361.
2012. View Article : Google Scholar
|
|
2
|
Patchell RA: The management of brain
metastasis. Cancer Treat Rev. 29:533–540. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Balch CM, Houghton AN, Sober AJ and Soong
SJ: Cutaneous Melanoma. 4th. Quality Medical Publishing; St. Louis,
MO, USA: 2003
|
|
4
|
Balch CM, Gershenwald JE, Soong SJ,
Thompson JF, Atkins MB, Byrd DR, Buzaid AC, Cochran AJ, Coit DG,
Ding S, et al: Final version of 2009 AJCC melanoma staging and
classification. J Clin Oncol. 27:6199–6206. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Budman DR, Camacho E and Wittes RE: The
current causes of death in patients with malignant melanoma. Eur J
Cancer. 14:327–330. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Davies MA, Liu P, McIntyre S, Kim KB,
Papadopoulos N, Hwu WJ, Hwu P and Bedikian A: Prognostic factors
for survival in melanoma patients with brain metastases. Cancer.
117:1687–1696. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Patel JK, Didolkar MS, Pickern JW and
Moore RH: Metastatic pattern of malignant melanoma: A study of 216
autopsy cases. Am J Surg. 135:807–810. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ravdel L, Robinson WA, Lewis K and
Gonzalez R: Metastatic melanoma in the breast: A report of 27
cases. J Surg Oncol. 94:101–104. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Al Samaraee A, Khout H, Barakat T and
Fasih T: Breast Metastasis from a melanoma. Ochsner J. 12:149–151.
2012.PubMed/NCBI
|
|
10
|
Thomson JF, Scolyer RA and Kefford RF:
Cutaneous melanoma. Lancet. 365:687–701. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rapidis AD, Apostolidis C, Vilos G and
Valsamis S: Primary malignant melanoma of the oral mucosa. J Oral
Maxillofac Surg. 61:1132–1139. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shen ZY, Liu W, Bao ZX, Zhou ZT and Wang
LZ: Oral melanotic macule and primary oral malignant melanoma:
Epidemiology, location involved, and clinical implications. Oral
Surg Oral Med Oral pathol Oral Radiol Endod. 112:e21–e25. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Patel SG, Prasad ML, Escrig M, Singh B,
Shaha AR, Kraus DH, Boyle JO, Huvos AG, Busam K and Shah JP:
Primary mucosal malignant melanoma of the head and neck. Head Neck.
24:247–257. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Keller DS, Thomay AA, Gaughan L, Olszanski
A, Wu H, Berger AC and Farma JM: Outcomes in patients with mucosal
melanomas. J Surg Oncol. 108:516–520. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tlholoe MM, Khammissa RA, Bouckaert M,
Altini M, Lemmer J and Feller L: Oral mucosal melanoma: Some
pathobiological considerations and illustrative report of a case.
Head Neck Pathol. 9:127–134. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kumar K, Santhosh BS and Priya NK: Primary
oral malignant melanoma-a case report. Nig Dent J. 19:44–47.
2011.
|
|
17
|
Jayaraj SM, Hern JD, Mochloulis G and
Porter GC: Malignant melanoma arising in the frontal sinuses. J
Laryngol Otol. 111:376–378. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Thompson AC, Morgan DA and Bradely PJ:
Malignant melanoma of the nasal cavity and paranasal sinuses. Clin
Otolaryngol Allied Sci. 18:34–36. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gilligan D and Selvin NJ: Radical
radiotherapy for 28 cases of mucosal melanoma in the nasal cavity
and sinuses. Br J Radiol. 64:1147–1150. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chiarion-Sileni V, Murr R, Pigozzo J,
Sarti S, Tomassi O and Romanini A: Brain metastases from malignant
melanoma. Forum (Genova). 13:170–182. 2003.PubMed/NCBI
|
|
21
|
Cohn-Cedermark G, Måsson-Brahme E,
Rutqvist LE, Larsson O, Johansson H and Ringborg U: Central nervous
system metastases of cutaneous malignant melanoma-a population
based study. Acta Oncol. 37:463–470. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Korn EL, Liu PY, Lee SJ, Chapman JA,
Niedzwiecki D, Suman VJ, Moon J, Sondak VK, Atkins MB, Eisenhauer
EA, et al: Meta-analysis of phase II cooperative group trials in
metastatic stage IV melanoma to determine progression-free survival
and overall survival benchmarks for future phase II trials. J Clin
Oncol. 26:527–534. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vecchio S, Spagnolo F, Merlo DF, Signori
A, Acquati M, Pronzato P and Queirolo P: The treatment of melanoma
brain metastases before the advent of targeted therapies:
Associations between therapeutic choice, clinical symptoms and
outcome with survival. Melanoma Res. 24:61–67. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Agarwala SS, Kirkwood JM, Gore M, Dreno B,
Thatcher N, Czarnetski B, Atkins M, Buzaid A, Skarlos D and Rankin
EM: Temozolomide for treatment of brain metastases associated with
metastatic melanoma: A phase II study. J Clin Oncol. 22:2101–2107.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Margolin K, Atkins M, Thomson J, Ernstoff
S, Weber J, Flaherty L, Clark I, Weiss G, Sosman J, II Smith W, et
al: Temozolomide and whole brain radiation in melanoma metastatic
to the brain: A phase II trial of the cytokine working group. J
Cancer Res Clin Oncol. 128:214–218. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fodi FS, O'Day SJ, McDermott DF, Weber RW,
Sosman JA, Haanen JB, Gonzalez R, Robert C, Schadendorf D, Hassel
JC, et al: Improved survival with ipilimumab in patients with
metastatic melanoma. N Engl J Med. 363:711–723. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
McArthur GA, Chapman PB, Robert C, Larkin
J, Haanen JB, Dummer R, Ribas A, Hogg D, Hamid O, Ascierto PA, et
al: Safety and efficacy of vemurafenib in BRAF(V600E) and
BRAF(V600K) mutation-positive melanoma (BRIM-3): Extended follow-up
of a phase 3, randomised, open-label study. Lancet Oncol.
15:323–332. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Long GV, Stroyakovskiy D, Gogas H,
Levchenko E, De Braud F, Larkin J, Garbe C, Jouary T, Hauschild A,
Grob JJ, et al: Dabrafenib and trametinib versus dabrafenib and
placebo for Val600 BRAF-mutant melanoma: A multicenter, double
blind, phase 3 randomised controlled trial. Lancet. 386:444–451.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Spagnolo F, Picasso V, Lambertini M,
Ottaviano V, Dozin B and Queirolo P: Survival of patients with
metastatic melanoma and brain metastases in era of MAP-kinase
inhibitors and immunologic checkpoint blockade antibodies: A
systemic review. Cancer Treat Rev. 45:38–45. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cabrero I Alvarado, Alvarez M Carrera,
Pérez Montiel D and Tavassoil FA: Metastases to the breast. Eur J
Surg Oncol. 29:854–855. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Toombs BD and Kalisher L: Metastatic
disease to the breast: Clinical, pathologic, and radiographic
features. AM J Roentgenol. 129:673–676. 1977. View Article : Google Scholar
|
|
32
|
Georgiannos SN, Chin J, Goode AW and
Sheaff M: Secondary neoplasms of the breast: A survey of the 20th
century. Cancer. 92:2259–2266. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Amichetti M, Perani B and Boi S:
Metastases to the breast from extra-mammary malignancies. Oncology.
47:257–260. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Vergier B, Trojani M, De Mascarel I,
Coindre JM and Le Treut A: Metastases to the breast: Differential
diagnosis from primary breast carcinoma. J Surg Oncol. 48:112–116.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lee SH, Park JM, Kook SH, Han BK and Moon
WK: Metastatic tumors to the breast: Mammographic and
ultrasonographic findings. J Ultrasound Med. 19:257–262. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Arora R and Robinson WA: Breast metastases
from malignant melanoma. J Surg Oncol. 50:27–29. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Miller JG and Mac Neil S: Gender and
cutaneous melanoma. Br J Dermatol. 136:657–665. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Davey RJ, van der Westhuizen A and Bowden
NA: Metastatic melanoma treatment: Combining old and new therapies.
Crit Rev Oncol Hematol. 98:242–253. 2016. View Article : Google Scholar : PubMed/NCBI
|
